Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Epitheliod Malignant Pleural Mesothelioma × 1-phenyl-3,3-dimethyltriazene × 1 year × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Pleural Diseases 2 Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Non-Muscle Invasive Bladder Neoplasms 1 Mesothelioma, Malignant 1 Keratosis, Actinic 1 Glioma 1 Glioblastoma 1 Epitheliod Malignant Pleural Mesothelioma 1 Carcinoma, Transitional Cell 1 Carcinoma, Basal Cell 1

Interventions

Photochemotherapy 1 Drug Therapy 1 Dihematoporphyrin Ether 1 1-phenyl-3,3-dimethyltriazene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02153229 2025-12-26

MPM-PDT

Abramson Cancer Center at Penn Medicine

Phase 2 Active not recruiting

Other solid neoplasmThoracic

Epitheliod Malignant Pleural Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡